Barry E. Greene, President at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 92,236 shares at $122.66 ($11.0M) on 2020-09-09, disclosed to the SEC on 2020-09-11.
Open-market sale of $11.0M ALNY by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,176 | $0 | 0.0% |
| 2 | $122.66 | 14,075 | $1.7M | 15.7% |
| 3 | $122.66 | 14,075 | $1.7M | 15.7% |
| 4 | $123.39 | 27,109 | $3.3M | 30.5% |
| 5 | $123.39 | 27,109 | $3.3M | 30.5% |
| 6 | $124.38 | 3,346 |
| $416K |
| 3.8% |
| 7 | $124.38 | 3,346 | $416K | 3.8% |
| Total | $118.99 avg | 92,236 | $11.0M | 100% |
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |
| ALNY | SELL | 2020-05-07 | $6.7M | — | Filing → |